Study |
New bone formation (%) |
Residual graft material (%) |
Lamellar bone (%) |
---|---|---|---|
Lee et al. [19] | Autogenous teeth: 57.19 (11.16) | Not evaluated | Not evaluated |
Synthetic hydroxyapatite: 34.07 (13.09) | |||
No difference (P > 0.05)a | |||
Sohn et al. [20] |
Blood clots: 2 weeks: 8.46 (1.88), 4 weeks: 17.8 (2.63), 8 weeks: 12.1 (2.71) |
Blood clots: 2, 4, 8 weeks: not evaluated |
4 weeks: 2.21 (0.69), 8 weeks: 10.45 (2.1) |
Anorganic bovine bone: 2 weeks: 16.09 (1.52), 4 weeks: 18.91(1.96), 8 weeks: 19.65 (1.81) |
Anorganic bovine bone: 2 weeks: 36.74 (3.94), 4 weeks: 32.97 (2.59), 8 weeks: 35.21 (3.16) |
4 weeks: 1.48 (0.3), 8 weeks: 4.85 (0.47) |
|
β-TCP: 2 weeks: 15.05 (1.21), 4 weeks: 20.13 (2.3), 8 weeks: 20.73 (1.99) |
β-TCP: 2 weeks: 37.19 (3.08), 4 weeks: 29.43 (3.2), 8 weeks: 21.01 (3.4) |
4 weeks: 1.46 (0.4), 8 weeks: 4.04 (0.52) |
|
DTD: 2 weeks: 17.71 (2.2), 4 weeks: 20.73 (1.99), 8 weeks: 28.09 (1.51) |
DTD: 2 weeks: 44.41 (5.26), 4 weeks: 28.25 (3.68), 8 weeks: 14.04 (3.17) |
4 weeks: 1.31 (0.3), 8 weeks: 4.7 (0.59) |
|
At 8 weeks: significant greater in DTD group than β-TCP group |
DTD: significantly less than Bio-Oss® or β-TCP area at 8 weeks (P < 0.05) |
Significantly higher in blood clots group (P < 0.5) |
|
Xu et al. [21] |
DHT: 2 weeks: 5.54 (0.5), 8 weeks: 19.45 (2.06) |
DHT: 41.01 (2.23) and 9.62 (1.02); P < 0.5 | 8 weeks: 6.08 (0.65) |
Bio-Oss®: 2 weeks: 5.94 (0.36); 8 weeks: 4.83 (0.41) |
Bio-Oss®: 2 weeks: 29.03 (2.32), 8 weeks: 25.53 (2.15) |
8 weeks: 5.36 (0.45) | |
Significantly higher in DHT group | - | Increased amount in DHT (P < 0.5) |
aNo statistical significant difference due to small number of experimented animals.
|